Travoprost/Timolol Maleate

曲伏前列素/马来酸噻吗洛尔

Report date: 2023/01/18 10:54:10

Base Information

Drug NameTravoprost/Timolol Maleate
Drug Alias NameTravoprost/timolol噻吗洛尔曲伏前列素Timolol and Travoprost曲伏前列素噻吗洛尔Travoprost and timolol +[14] 
ClassificationSmall molecules
Mechanisms of ActionBeta adrenergic receptors antagonistsProstanoid FP receptor agonists
TargetsProstanoid FP receptorBeta adrenergic receptors
Therapy Area/IndicationsGlaucoma, Open-AngleGlaucomaOcular Hypertension
Global Approved IndicationsGlaucoma, Open-AngleGlaucomaOcular Hypertension
Approved Indications in ChinaGlaucoma, Open-AngleOcular Hypertension
Original Approved Country/TerritoryAustralia
Original Approved Date2005/07/01
Country/TerritoryBelgiumUnited StatesAustralia +[6] 
CombinationsYes TravoprostTimolol Maleate
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAlcon
China Registration ClassN/A

Develop Information

Active CompaniesAlconNovartis Europharm Ltd
Inactive CompaniesN/A
Active IndicationsGlaucoma, Open-AngleGlaucomaOcular Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeS01ED51
Related LinksKEGG